ULBI — Ultralife Cashflow Statement
0.000.00%
Last trade - 00:00- $106.27m
- $146.71m
- $191.16m
Annual cashflow statement for Ultralife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.23 | -0.12 | 7.17 | 6.41 | -5.95 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.775 | 0.812 | 0.592 | 0.951 | 13.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.388 | -5.45 | -11 | 3.89 | 0.602 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 4.33 | -1.26 | 1.93 | 16.6 | 11 |
| Capital Expenditures | -2.81 | -1.68 | -2.55 | -1.93 | -3.87 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -23.5 | 0 | — | -48 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -26.3 | -1.68 | -2.55 | -50 | -3.87 |
| Financing Cash Flow Items | -0.262 | -0.115 | -0.008 | -1.39 | -0.024 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.6 | 0.518 | 5.49 | 29.9 | -4.68 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.24 | -2.7 | 4.57 | -3.42 | 2.49 |